News
12-10-2008, 06:23 AM
Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute. Numerous regimens have been tested in advanced breast cancer.
More... (http://www.medicalnewstoday.com/articles/132467.php)
More... (http://www.medicalnewstoday.com/articles/132467.php)